Re:Non-profit’s $300 hepatitis C cure as effective as $84k a...
by inasio on Thursday April 12, 2018 @12:18PM
(#16822404)
In the US efficacy is typically measured through estimates of DALYs (disability-adjusted life years). Following WHO guidelines, cost of an intervention (or drug) up to three times the national per-capita GPD (~3x50K in the US) is considered to be cost-effective.
[ Parent
| on HN ]